Oblong, Inc. (Nasdaq: OBLG) (“Oblong” or the “Company”), the award-winning maker of multi-stream collaboration solutions, today reported financial results for the third quarter ending September 30, 2022.
“Our results for the third quarter came in as previously expected and, while our sales and profit results do not yet reflect the strategic and financial actions taken in recent quarters to shift our performance, we are confident in our stated objective to pursue growth both organically and through inorganic means that may include a business combination or sale of the company. Lastly, I want to thank our team for their proven dedication and resilience during this extraordinary and important time for our organization,” commented Pete Holst, President & CEO of Oblong.
- As of September 30, 2022, the Company had $4.1 million of cash and no debt.
- Total revenue was $1.2 million for the third quarter of 2022 versus $1.8 million for the third quarter of 2021.
- Net loss of $7.2 million for the third quarter of 2022, compared to a net loss of $0.7 million for the third quarter of 2021. During the third quarter of 2022, the Company recorded non-cash impairment charges on intangible and other assets of $5.2 million.
- Adjusted EBITDA (“AEBITDA”) loss of $1.4 million for the third quarter of 2022, compared to an AEBITDA loss of $1.7 million for the third quarter of 2021. AEBITDA loss is a non-GAAP financial measure. See “Non-GAAP Financial Information” below for additional information regarding this non-GAAP financial measure, and “GAAP to Non-GAAP Reconciliation” for a reconciliation of this non-GAAP financial measure to net loss.
Non-GAAP Financial Information
Adjusted EBITDA (“AEBITDA”) loss, a non-GAAP financial measure, is defined as net loss before depreciation and amortization, stock-based compensation and expense, impairment charges, casualty loss, gain on extinguishment of debt, severance, income tax expense, and interest and other (income) expense, net. AEBITDA loss is not intended to replace operating loss, net loss, cash flow or other measures of financial performance reported in accordance with generally accepted accounting principles (GAAP). Rather, AEBITDA loss is an important measure used by management to assess the operating performance of the Company and to compare such performance between periods. AEBITDA loss as defined here may not be comparable to similarly titled measures reported by other companies due to differences in accounting policies. Therefore, AEBITDA loss should be considered in conjunction with net loss and other performance measures prepared in accordance with GAAP, such as operating loss or cash flow used in operating activities, and should not be considered in isolation or as a substitute for GAAP measures, such as net loss, operating loss or any other GAAP measure of liquidity or financial performance. A GAAP to non-GAAP reconciliation of net loss to AEBITDA loss is shown under “GAAP to Non-GAAP Reconciliation” later in this release.
About Oblong, Inc.
Oblong (Nasdaq:OBLG) provides innovative and patented technologies that change the way people work, create, and communicate. Oblong’s flagship product Mezzanine™ is a remote meeting technology platform that offers simultaneous content sharing to achieve situational awareness for both in-room and remote collaborators. Oblong supplies Mezzanine systems to Fortune 500 and enterprise customers. For more information, visit www.oblong.com and Oblong’s Twitter and Facebook pages.
Forward looking and cautionary statements
This press release and any oral statements made regarding the subject of this release contain forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, that address activities that Oblong assumes, plans, expects, believes, intends, projects, estimates or anticipates (and other similar expressions) will, should or may occur in the future are forward-looking statements. Oblong’s actual results may differ materially from its expectations, estimates and projections, and consequently you should not rely on these forward-looking statements as predictions of future events. Without limiting the generality of the foregoing, forward-looking statements contained in this press release include statements relating to (i) the Company exploring strategic alternatives to maximize value for our shareholders and the timing and results thereof, (ii) the Company’s potential future growth and financial performance, and (iii) the success of its products and services. There can be no assurance that the strategic review being undertaken will result in a merger, sale or other business combination involving the Company. The forward-looking statements are based on management’s current belief, based on currently available information, as to the outcome and timing of future events, and involve factors, risks, and uncertainties, including the volatility of market price for our securities, that may cause actual results in future periods to differ materially from such statements. A list and description of these and other risk factors can be found in the Company’s Annual Report on Form 10-K for the year ending December 31, 2021 and in other filings made by the Company with the SEC from time to time. Any of these factors could cause Oblong’s actual results and plans to differ materially from those in the forward-looking statements. Therefore, the Company can give no assurance that its future results will be as estimated. The Company does not intend to, and disclaims any obligation to, correct, update, or revise any information contained herein.
|
OBLONG, INC. CONDENSED CONSOLIDATED BALANCE SHEETS ($ in thousands) |
|||||||
|
|
September 30, 2022 |
|
December 31, 2021 |
||||
|
|
(Unaudited) |
|
|
||||
|
ASSETS |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash |
$ |
4,143 |
|
|
$ |
8,939 |
|
|
Restricted cash |
|
— |
|
|
|
61 |
|
|
Accounts receivable, net |
|
357 |
|
|
|
849 |
|
|
Inventory |
|
1,027 |
|
|
|
1,821 |
|
|
Prepaid expenses and other current assets |
|
868 |
|
|
|
1,081 |
|
|
Total current assets |
|
6,395 |
|
|
|
12,751 |
|
|
Property and equipment, net |
|
25 |
|
|
|
159 |
|
|
Goodwill |
|
— |
|
|
|
7,367 |
|
|
Intangibles, net |
|
690 |
|
|
|
7,562 |
|
|
Right-of-use assets, net |
|
201 |
|
|
|
659 |
|
|
Other assets |
|
53 |
|
|
|
109 |
|
|
Total assets |
$ |
7,364 |
|
|
$ |
28,607 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Accounts payable |
|
401 |
|
|
|
259 |
|
|
Accrued expenses and other current liabilities |
|
1,088 |
|
|
|
959 |
|
|
Current portion of deferred revenue |
|
571 |
|
|
|
783 |
|
|
Current portion of operating lease liabilities |
|
306 |
|
|
|
492 |
|
|
Total current liabilities |
|
2,366 |
|
|
|
2,493 |
|
|
Long-term liabilities: |
|
|
|
||||
|
Operating lease liabilities, net of current portion |
|
43 |
|
|
|
236 |
|
|
Deferred revenue, net of current portion |
|
152 |
|
|
|
381 |
|
|
Total long-term liabilities |
|
195 |
|
|
|
617 |
|
|
Total liabilities |
|
2,561 |
|
|
|
3,110 |
|
|
Commitments and contingencies |
|
|
|
||||
|
Stockholders’ equity: |
|
|
|
||||
|
Common stock, $.0001 par value; 150,000,000 shares authorized; 30,929,331 shares issued and 30,816,048 outstanding at September 30, 2022 and December 31, 2021 |
|
3 |
|
|
|
3 |
|
|
Treasury stock, 113,283 shares of common stock at September 30, 2022 and December 31, 2021 |
|
(181 |
) |
|
|
(181 |
) |
|
Additional paid-in capital |
|
227,611 |
|
|
|
227,581 |
|
|
Accumulated deficit |
|
(222,630 |
) |
|
|
(201,906 |
) |
|
Total stockholders’ equity |
|
4,803 |
|
|
|
25,497 |
|
|
Total liabilities and stockholders’ equity |
$ |
7,364 |
|
|
$ |
28,607 |
|
|
OBLONG, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS ($ in thousands) (Unaudited) |
|||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||
|
|
September 30, |
|
September 30, |
||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
Revenue |
$ |
1,185 |
|
|
$ |
1,799 |
|
|
4,050 |
|
|
5,766 |
|
|
Cost of revenue (exclusive of depreciation and amortization and casualty loss) |
|
841 |
|
|
|
1,228 |
|
|
2,800 |
|
|
3,767 |
|
|
Gross profit |
|
344 |
|
|
|
571 |
|
|
1,250 |
|
|
1,999 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
||||||
|
Research and development |
|
232 |
|
|
|
693 |
|
|
1,634 |
|
|
1,984 |
|
|
Sales and marketing |
|
282 |
|
|
|
438 |
|
|
1,161 |
|
|
1,537 |
|
|
General and administrative |
|
1,229 |
|
|
|
1,628 |
|
|
4,104 |
|
|
5,078 |
|
|
Impairment charges |
|
5,169 |
|
|
|
254 |
|
|
12,715 |
|
|
302 |
|
|
Casualty loss |
|
— |
|
|
|
— |
|
|
533 |
|
|
— |
|
|
Depreciation and amortization |
|
592 |
|
|
|
669 |
|
|
1,818 |
|
|
2,098 |
|
|
Total operating expenses |
|
7,504 |
|
|
|
3,682 |
|
|
21,965 |
|
|
10,999 |
|
|
Loss from operations |
|
(7,160 |
) |
|
|
(3,111 |
) |
|
(20,715 |
) |
|
(9,000 |
) |
|
Interest and other expense (income), net |
|
(5 |
) |
|
|
(2,449 |
) |
|
1 |
|
|
(2,659 |
) |
|
Loss before income taxes |
|
(7,155 |
) |
|
|
(662 |
) |
|
(20,716 |
) |
|
(6,341 |
) |
|
Income tax expense (benefit) |
|
(3 |
) |
|
|
— |
|
|
8 |
|
|
— |
|
|
Net loss |
$ |
(7,152 |
) |
|
$ |
(662 |
) |
|
(20,724 |
) |
|
(6,341 |
) |
|
GAAP to Non-GAAP Reconciliation: |
|||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
September 30, |
|
September 30, |
||||||||||||
|
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
Net loss |
$ |
(7,152 |
) |
|
$ |
(662 |
) |
|
$ |
(20,724 |
) |
|
$ |
(6,341 |
) |
|
Depreciation and amortization |
|
592 |
|
|
|
669 |
|
|
|
1,818 |
|
|
|
2,098 |
|
|
Interest and other expense (income), net |
|
(5 |
) |
|
|
(2,449 |
) |
|
|
1 |
|
|
|
(2,659 |
) |
|
Income tax expense (benefit) |
|
(3 |
) |
|
|
— |
|
|
|
8 |
|
|
|
— |
|
|
Impairment charges |
|
5,169 |
|
|
|
254 |
|
|
|
12,715 |
|
|
|
302 |
|
|
Severance |
|
— |
|
|
|
12 |
|
|
|
294 |
|
|
|
23 |
|
|
Casualty loss |
|
— |
|
|
|
— |
|
|
|
533 |
|
|
|
— |
|
|
Stock-based expense |
|
31 |
|
|
|
502 |
|
|
|
30 |
|
|
|
925 |
|
|
Adjusted EBITDA Loss |
$ |
(1,368 |
) |
|
$ |
(1,674 |
) |
|
$ |
(5,325 |
) |
|
$ |
(5,652 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005966/en/